AceIMMune-STING Agonist: Formulation and In vitro/In vivo Evaluation for Treating Colitis
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
IMMvention Therapeutix
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Anil Goyal
Fiscal Year
2020
Region
Research Triangle
Project Description:
IMMVention’s novel AceIMMune technology is designed to deliver innate immunomodulatory drugs to immune cells and initiate responses to treat autoimmune conditions. IMMVention will use the SRL to fund IND-enabling activities for the treatment of ulcerative colitis.